US Stock MarketDetailed Quotes

ADMA Biologics (ADMA)

Watchlist
  • 8.500
  • +0.090+1.07%
Close May 13 15:59 ET
  • 8.680
  • +0.180+2.12%
Post 20:01 ET
1.97BMarket Cap12.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ADMA Biologics (ADMA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
396.06%58.25M
-57.53%50.4M
-29.03%35.64M
-46.89%13.29M
-53.69%21.14M
-787.06%-19.68M
1,248.55%118.67M
185.37%50.22M
108.83%25.03M
853.36%45.65M
Net income from continuing operations
68.48%45.33M
-25.67%146.93M
-55.87%49.38M
1.45%36.43M
6.72%34.22M
51.10%26.9M
800.00%197.67M
734.15%111.9M
1,299.42%35.91M
603.25%32.06M
Operating gains losses
---7.94M
147.96%3.35M
-99.32%9K
27,112.50%2.18M
----
----
-94.88%1.35M
-94.98%1.32M
-91.40%8K
--1K
Depreciation and amortization
-6.60%1.84M
0.63%8.1M
5.25%2.05M
4.28%2.02M
0.54%2.06M
-6.86%1.97M
-3.44%8.05M
-7.82%1.94M
-7.27%1.94M
-2.43%2.05M
Deferred tax
-3.88%3.29M
113.08%11.02M
101.39%1.17M
--4.8M
--1.62M
--3.43M
---84.28M
---84.28M
--0
--0
Other non cash items
0.65%155K
-28.96%574K
-12.02%161K
-37.96%134K
-34.90%125K
-29.03%154K
-87.15%808K
-88.11%183K
-87.13%216K
-88.28%192K
Change In working capital
116.29%9.24M
-652.98%-139.6M
-264.10%-22.52M
-130.03%-37.32M
-371.24%-23M
-131.46%-56.75M
-83.14%-18.54M
280.77%13.72M
-520.20%-16.22M
267.58%8.48M
-Change in receivables
145.67%22.57M
-380.25%-108.43M
-14,820.57%-20.76M
-39.55%-27.95M
-152.87%-10.31M
-122.58%-49.41M
-89.48%-22.58M
-96.38%141K
-469.98%-20.03M
290.99%19.51M
-Change in inventory
-700.46%-15.63M
-1,456.42%-36.23M
-725.67%-9.8M
-164.96%-5.2M
-827.62%-19.28M
59.53%-1.95M
127.75%2.67M
116.00%1.57M
699.48%8.01M
-194.24%-2.08M
-Change in prepaid assets
50.65%-1.22M
53.51%-1.25M
-100.36%-7K
126.63%1.16M
108.63%75K
-505.24%-2.48M
-418.67%-2.68M
-6.36%1.94M
-5,961.11%-4.36M
59.88%-869K
-Change in payables and accrued expense
271.40%3.87M
45.26%7.54M
-18.63%8.44M
-457.18%-5.1M
182.61%6.46M
-285.32%-2.26M
-54.33%5.19M
35.49%10.37M
1,041.60%1.43M
-249.88%-7.82M
-Change in other current liabilities
47.69%-340K
-7.60%-1.23M
-34.35%-395K
81.56%-234K
118.60%48K
-196.01%-650K
-44.63%-1.14M
-27.83%-294K
-371.75%-1.27M
-145.71%-258K
Cash from discontinued investing activities
Operating cash flow
396.06%58.25M
-57.53%50.4M
-29.03%35.64M
-46.89%13.29M
-53.69%21.14M
-787.06%-19.68M
1,248.55%118.67M
185.37%50.22M
108.83%25.03M
853.36%45.65M
Investing cash flow
Cash flow from continuing investing activities
150.93%2.4M
-155.29%-21.89M
89.96%-276K
-1,208.56%-14.37M
-6.85%-2.53M
-99.83%-4.72M
-72.15%-8.58M
-95.45%-2.75M
-45.05%-1.1M
-171.22%-2.37M
Net PPE purchase and sale
45.91%-2.54M
-174.43%-22.58M
60.68%-1.08M
-1,260.61%-14.37M
-17.23%-2.42M
-100.30%-4.7M
-72.42%-8.23M
-130.33%-2.76M
-39.50%-1.06M
-136.93%-2.07M
Net intangibles purchase and sale
-178.95%-53K
9.46%-316K
-2,842.86%-192K
--0
64.88%-105K
-26.67%-19K
-66.19%-349K
103.33%7K
---42K
---299K
Net other investing changes
--5M
--1M
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
150.93%2.4M
-155.29%-21.89M
89.96%-276K
-1,208.56%-14.37M
-6.85%-2.53M
-99.83%-4.72M
-72.15%-8.58M
-95.45%-2.75M
-45.05%-1.1M
-171.22%-2.37M
Financing cash flow
Cash flow from continuing financing activities
-42.14%-10.13M
24.49%-44.02M
70.61%-9.12M
-9.26%-27.83M
113.26%48K
-392.54%-7.13M
-49.53%-58.3M
20.44%-31.03M
-6,221.88%-25.47M
-250.83%-362K
Net issuance payments of debt
--124.53M
98.44%-938K
98.44%-469K
98.44%-469K
--0
--0
-154.23%-60M
-27.20%-30M
---30M
--0
Net common stock issuance
---130.19M
---31.94M
---8.9M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
482.18%588K
-60.18%2.98M
-2.93%430K
-93.16%389K
523.56%2.06M
-90.18%101K
578.80%7.49M
5,437.50%443K
812.02%5.69M
-29.87%331K
Net other financing activities
30.02%-5.06M
-143.75%-14.13M
87.95%-177K
-306.48%-4.71M
-190.91%-2.02M
-191.92%-7.23M
64.86%-5.8M
90.47%-1.47M
-456.73%-1.16M
-206.64%-693K
Cash from discontinued financing activities
Financing cash flow
-42.14%-10.13M
24.49%-44.02M
70.61%-9.12M
-9.26%-27.83M
113.26%48K
-392.54%-7.13M
-49.53%-58.3M
20.44%-31.03M
-6,221.88%-25.47M
-250.83%-362K
Net cash flow
Beginning cash position
-15.04%87.63M
100.86%103.15M
-29.20%61.39M
2.31%90.29M
58.03%71.63M
100.86%103.15M
-40.65%51.35M
16.92%86.71M
41.16%88.24M
-34.51%45.33M
Current changes in cash
260.28%50.52M
-129.96%-15.52M
59.64%26.25M
-1,780.29%-28.9M
-56.52%18.66M
-423.01%-31.52M
247.27%51.8M
172.09%16.44M
-113.20%-1.54M
741.44%42.92M
End cash Position
92.88%138.15M
-15.04%87.63M
-15.04%87.63M
-29.20%61.39M
2.31%90.29M
58.03%71.63M
100.86%103.15M
100.86%103.15M
16.92%86.71M
41.16%88.24M
Free cash flow
328.13%55.65M
-75.02%27.51M
-27.61%34.36M
-104.49%-1.08M
-57.00%18.61M
-432.64%-24.4M
2,782.88%110.1M
193.18%47.47M
113.13%23.93M
724.46%43.28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 396.06%58.25M-57.53%50.4M-29.03%35.64M-46.89%13.29M-53.69%21.14M-787.06%-19.68M1,248.55%118.67M185.37%50.22M108.83%25.03M853.36%45.65M
Net income from continuing operations 68.48%45.33M-25.67%146.93M-55.87%49.38M1.45%36.43M6.72%34.22M51.10%26.9M800.00%197.67M734.15%111.9M1,299.42%35.91M603.25%32.06M
Operating gains losses ---7.94M147.96%3.35M-99.32%9K27,112.50%2.18M---------94.88%1.35M-94.98%1.32M-91.40%8K--1K
Depreciation and amortization -6.60%1.84M0.63%8.1M5.25%2.05M4.28%2.02M0.54%2.06M-6.86%1.97M-3.44%8.05M-7.82%1.94M-7.27%1.94M-2.43%2.05M
Deferred tax -3.88%3.29M113.08%11.02M101.39%1.17M--4.8M--1.62M--3.43M---84.28M---84.28M--0--0
Other non cash items 0.65%155K-28.96%574K-12.02%161K-37.96%134K-34.90%125K-29.03%154K-87.15%808K-88.11%183K-87.13%216K-88.28%192K
Change In working capital 116.29%9.24M-652.98%-139.6M-264.10%-22.52M-130.03%-37.32M-371.24%-23M-131.46%-56.75M-83.14%-18.54M280.77%13.72M-520.20%-16.22M267.58%8.48M
-Change in receivables 145.67%22.57M-380.25%-108.43M-14,820.57%-20.76M-39.55%-27.95M-152.87%-10.31M-122.58%-49.41M-89.48%-22.58M-96.38%141K-469.98%-20.03M290.99%19.51M
-Change in inventory -700.46%-15.63M-1,456.42%-36.23M-725.67%-9.8M-164.96%-5.2M-827.62%-19.28M59.53%-1.95M127.75%2.67M116.00%1.57M699.48%8.01M-194.24%-2.08M
-Change in prepaid assets 50.65%-1.22M53.51%-1.25M-100.36%-7K126.63%1.16M108.63%75K-505.24%-2.48M-418.67%-2.68M-6.36%1.94M-5,961.11%-4.36M59.88%-869K
-Change in payables and accrued expense 271.40%3.87M45.26%7.54M-18.63%8.44M-457.18%-5.1M182.61%6.46M-285.32%-2.26M-54.33%5.19M35.49%10.37M1,041.60%1.43M-249.88%-7.82M
-Change in other current liabilities 47.69%-340K-7.60%-1.23M-34.35%-395K81.56%-234K118.60%48K-196.01%-650K-44.63%-1.14M-27.83%-294K-371.75%-1.27M-145.71%-258K
Cash from discontinued investing activities
Operating cash flow 396.06%58.25M-57.53%50.4M-29.03%35.64M-46.89%13.29M-53.69%21.14M-787.06%-19.68M1,248.55%118.67M185.37%50.22M108.83%25.03M853.36%45.65M
Investing cash flow
Cash flow from continuing investing activities 150.93%2.4M-155.29%-21.89M89.96%-276K-1,208.56%-14.37M-6.85%-2.53M-99.83%-4.72M-72.15%-8.58M-95.45%-2.75M-45.05%-1.1M-171.22%-2.37M
Net PPE purchase and sale 45.91%-2.54M-174.43%-22.58M60.68%-1.08M-1,260.61%-14.37M-17.23%-2.42M-100.30%-4.7M-72.42%-8.23M-130.33%-2.76M-39.50%-1.06M-136.93%-2.07M
Net intangibles purchase and sale -178.95%-53K9.46%-316K-2,842.86%-192K--064.88%-105K-26.67%-19K-66.19%-349K103.33%7K---42K---299K
Net other investing changes --5M--1M--------------------------------
Cash from discontinued investing activities
Investing cash flow 150.93%2.4M-155.29%-21.89M89.96%-276K-1,208.56%-14.37M-6.85%-2.53M-99.83%-4.72M-72.15%-8.58M-95.45%-2.75M-45.05%-1.1M-171.22%-2.37M
Financing cash flow
Cash flow from continuing financing activities -42.14%-10.13M24.49%-44.02M70.61%-9.12M-9.26%-27.83M113.26%48K-392.54%-7.13M-49.53%-58.3M20.44%-31.03M-6,221.88%-25.47M-250.83%-362K
Net issuance payments of debt --124.53M98.44%-938K98.44%-469K98.44%-469K--0--0-154.23%-60M-27.20%-30M---30M--0
Net common stock issuance ---130.19M---31.94M---8.9M----------0--0--0--------
Proceeds from stock option exercised by employees 482.18%588K-60.18%2.98M-2.93%430K-93.16%389K523.56%2.06M-90.18%101K578.80%7.49M5,437.50%443K812.02%5.69M-29.87%331K
Net other financing activities 30.02%-5.06M-143.75%-14.13M87.95%-177K-306.48%-4.71M-190.91%-2.02M-191.92%-7.23M64.86%-5.8M90.47%-1.47M-456.73%-1.16M-206.64%-693K
Cash from discontinued financing activities
Financing cash flow -42.14%-10.13M24.49%-44.02M70.61%-9.12M-9.26%-27.83M113.26%48K-392.54%-7.13M-49.53%-58.3M20.44%-31.03M-6,221.88%-25.47M-250.83%-362K
Net cash flow
Beginning cash position -15.04%87.63M100.86%103.15M-29.20%61.39M2.31%90.29M58.03%71.63M100.86%103.15M-40.65%51.35M16.92%86.71M41.16%88.24M-34.51%45.33M
Current changes in cash 260.28%50.52M-129.96%-15.52M59.64%26.25M-1,780.29%-28.9M-56.52%18.66M-423.01%-31.52M247.27%51.8M172.09%16.44M-113.20%-1.54M741.44%42.92M
End cash Position 92.88%138.15M-15.04%87.63M-15.04%87.63M-29.20%61.39M2.31%90.29M58.03%71.63M100.86%103.15M100.86%103.15M16.92%86.71M41.16%88.24M
Free cash flow 328.13%55.65M-75.02%27.51M-27.61%34.36M-104.49%-1.08M-57.00%18.61M-432.64%-24.4M2,782.88%110.1M193.18%47.47M113.13%23.93M724.46%43.28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -